Nicholas Corr

Nicholas Corr is a Blood Safety Scientist at Roche since October 2020, focusing on developing cost-effective predictive in vitro blood safety models with an emphasis on immunocompetent bone marrow models. Prior experience includes serving as a Hematopoietic and Immuno-toxicology Researcher at Genentech, where Nicholas developed custom in vitro assays to assess compound safety and efficacy. Additional roles include working as a Biological Technologies Quality Associate at Genentech, a Systems Verification Specialist at BD, and various positions in tutoring and logistics. Nicholas also has research experience from the University of San Francisco, where a focus was placed on herpesvirus and breast cancer research. An educational background includes a B.S. in Molecular, Cellular, and Developmental Biology from the University of California, Santa Cruz.